Showing results (1-10 of 146) with videos related to

Sort By:
Pageof 15
International Journal of Molecular Sciences|August 26, 2022
Monitoring of Current Cancer Therapy by Positron Emission Tomography and Possible Role of Radiomics AssessmentNoboru Oriuchi, Hideki Endoh, Kyoichi Kaira
Gan to Kagaku Ryoho. Cancer & Chemotherapy|August 21, 2025
[RI Therapy for Hematopoietic Tumors, Targeted α-Particle Therapy, and Future Prospects for Nuclear Medicine Therapies]Noboru Oriuchi, Songji Zhao, Takayuki Ikezoe
Biomedicines|September 25, 2020
Positron Emission Tomography for Response Evaluation in Microenvironment-Targeted Anti-Cancer TherapyNoboru Oriuchi, Shigeyasu Sugawara, Tohru Shiga
Kaku Igaku. the Japanese Journal of Nuclear Medicine|April 2, 2025
[New Investment for Theranostics in Europe]Kaori Nomura, Kohshin Washiyama, Noboru Oriuchi
International Journal of Cardiology|April 17, 2007
Gamma-delta T-cell-mediated dilated cardiomyopathyNorifumi Takeda, Yoshinori Seko, Noboru Oriuchi, et al.
Cancer Control : Journal of the Moffitt Cancer Center|November 1, 2005
Review of fluorine-18-2-fluoro-2-deoxy-D-glucose positron emission tomography (FDG-PET) in the follow-up of medullary and anaplastic thyroid carcinomasNasim Khan, Noboru Oriuchi, Tetsuya Higuchi, et al.
Annals of Nuclear Medicine|April 2, 2002
A shifting landscape: what will be next FDG in PET oncology?Tomio Inoue, Noboru Oriuchi, Katsumi Tomiyoshi, et al.
Annals of Nuclear Medicine|September 17, 2005
Current status of cancer therapy with radiolabeled monoclonal antibodyNoboru Oriuchi, Tetsuya Higuchi, Hirofumi Hanaoka, et al.
Annals of Nuclear Medicine|August 2, 2008
Variability of lesion detectability and standardized uptake value according to the acquisition procedure and reconstruction among five PET scannersYasuyuki Takahashi, Noboru Oriuchi, Hidenori Otake, et al.
Pageof 15